Stockscreener 앱 받기
10.47
3.68%
-0.40
전일 마감가:
$10.87
열려 있는:
$10.99
하루 거래량:
1.07M
Relative Volume:
0.76
시가총액:
$1.11B
수익:
-
순이익/손실:
$-258.08M
주가수익비율:
-3.8073
EPS:
-2.75
순현금흐름:
$-202.32M
1주 성능:
+0.00%
1개월 성능:
+3.05%
6개월 성능:
-47.65%
1년 성능:
-63.31%
1일 변동 폭
$10.42
$11.08
1주일 범위
$10.42
$11.11
52주 변동 폭
$9.33
$31.47
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
명칭
Rocket Pharmaceuticals Inc
전화
646-440-9100
주소
350 FIFTH AVENUE, NEW YORK, NY
RCKT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
10.47 | 1.11B | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-30 | 개시 | Wedbush | Outperform |
| 2024-12-18 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-04-02 | 개시 | Goldman | Neutral |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 개시 | Morgan Stanley | Overweight |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2022-11-01 | 개시 | BTIG Research | Buy |
| 2022-07-08 | 개시 | Raymond James | Outperform |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 개시 | JP Morgan | Overweight |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2019-11-06 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-26 | 개시 | Piper Jaffray | Overweight |
| 2019-04-23 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-02-05 | 개시 | Oppenheimer | Outperform |
| 2018-09-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-10 | 개시 | William Blair | Outperform |
모두보기
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
Rocket Pharmaceuticals (RCKT) Projected to Post Quarterly Earnings on Monday - Defense World
Long Term Trading Analysis for (RCKT) - Stock Traders Daily
2 Soaring Stocks to Hold for the Next 20 Years - The Globe and Mail
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week LowHere's Why - MarketBeat
Sovran Advisors LLC Acquires New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
RCKT stock touches 52-week low at $9.76 amid market challenges - MSN
Strategic Financial Concepts LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharma Is A Buy At These Prices With Promising Data (NASDAQ:RCKT) - Seeking Alpha
Jennison Associates LLC Purchases 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News
(RCKT) Long Term Investment Analysis - Stock Traders Daily
Rocket Pharmaceuticals Inc (RCKT) Shares Plummet Below 1-Year High - The News Heater
What was Rocket Pharmaceuticals Inc (RCKT)’s performance in the last session? - US Post News
Holdings of Rocket Pharmaceuticals Inc (RCKT) are aligned with the stars - SETE News
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by SG Americas Securities LLC - MarketBeat
SG Americas Securities LLC Acquires 48,793 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals appoints new board member By Investing.com - Investing.com Nigeria
Rocket Pharmaceuticals appoints new board member - Investing.com
Rocket Pharmaceuticals, Inc. Announces Board Changes -January 28, 2025 at 06:03 am EST - Marketscreener.com
Rocket Pharmaceuticals vice president sells $9,300 in stock - MSN
(RCKT) Technical Pivots with Risk Controls - Stock Traders Daily
Rocket Pharmaceuticals vice president sells $9,300 in stock By Investing.com - Investing.com Australia
Leerink Partnrs Has Strong Forecast for RCKT FY2024 Earnings - Defense World
FY2024 Earnings Estimate for RCKT Issued By Leerink Partnrs - MarketBeat
Analysts Offer Predictions for RCKT FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts RCKT FY2025 Earnings - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week LowHere's What Happened - MarketBeat
Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $47.27 - MarketBeat
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Hexcel (NYSE:HXL) Reports Sales Below Analyst Estimates In Q4 Earnings - The Globe and Mail
RCKT stock touches 52-week low at $10.11 amid market challenges - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low – Time to Sell? - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4%Here's Why - MarketBeat
How to Take Advantage of moves in (RCKT) - Stock Traders Daily
Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Acquired by Mirador Capital Partners LP - MarketBeat
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
3.05%
자본화:
|
볼륨(24시간):